(Natural News) Erin Olszewski, a nurse with experience in both Florida and New York hospitals, reveals that hydroxychloroquine (HCQ) and zinc are more effective Wuhan coronavirus (COVID-19) treatments. She shared this revelation to Dr. Bryan Ardis on the Sept. 22 edition of the latter’s “The Dr. Ardis Show” on Brighteon.TV. Olszewski adds that New York’s refusal to stick to the HCQ-zinc treatment has contributed to its hospitals being overwhelmed during the pandemic’s early days.
Olszewski is a traveling nurse who has blown the lid off the protocols used in New York’s Elmhurst Hospital. Prior to her stint in New York state, she has also worked in a Florida hospital. This has given her a unique perspective on how hospitals in the two states deal with COVID-19 patients.
Ardis asks why the U.S. still holds the No. 1 spot in COVID-19 deaths despite only representing 5 percent of the world’s total population. He continues: “Why is it that more Americans have died [while] being treated for COVID-19 than any other country in the entire world, even … two years later?”
The nurse answers: “It’s the protocol, and it has always been the protocol. [COVID-19] is not killing our patients. It’s the protocol that’s killing them and they know it.”
Olszewski then shares how the Florida hospital she worked in chose the HCQ-zinc treatment for COVID-19 patients. She tells Ardis: “I think Dr. [Vladimir] Zelenko early on discussed this. [If] this is such a new, novel virus, we don’t know what’s really going on. The CEO of [the] hospital system [I worked in] decided, ‘Why not try it?’ and sure enough, it was working so they continued to use it.”
Ardis then asks how long did patients taking the HCQ-zinc treatment typically stay in the hospital. “There really wasn’t [any hospitalizations] because we would send them home with the medication. [Patients would] go home and quarantine themselves. [We] didn’t admit all these patients,” Olszewski answers. (Related: New study: HCQ improves coronavirus infection survival rates by 200%.)
Olszewski discovers how New York state treats patients
According to Olszewski, many staff members at the Florida hospital she has worked have been furloughed – enabling her to travel to New York. She adds that the state led by Gov. Andrew Cuomo prohibits the HCQ-zinc treatment in hospitals, with those who dare question the ban getting sent home.
The nurse says: “[It] was mind-blowing to get to New York and realize that … the protocol was completely different. [It’s] very easy to recognize that [the state’s] protocol wasn’t working, [and] it made complete sense … why New York was so ‘overwhelmed’ according to what the rest of the world was looking at.”
In relation to this protocol causing more deaths and recoveries, Ardis also mentions a May 2020 memo by Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases. The top infectious disease doctor mandates hospitals to use remdesivir as the treatment drug of choice for COVID-19. However, it is worth noting that at the time of Fauci’s May 2020 memo, remdesivir was only experimental and had no approval from the Food and Drug Administration. “[Fauci] badmouthed … HCQ and said it is not to be used [as] it has been found to cause heart failure and death in COVID-19 patients,” Ardis continues.
Ardis has previously voiced out opposition to the use of remdesivir for COVID-19. During the Sept. 2 edition of “The Matrixxx Grooove Show” on Brighteon.tv, he told program hosts Jeff Pedersen and Shannon “Shady” Grove about the antiviral drug being a part of what he calls an “ICU cocktail.” According to Ardis, hospital administrators are “not being helpful” with their insistence on using remdesivir – which causes more harm than good.
He further explains that remdesivir causes acute kidney failure in 35 percent of patients who take it within five to 10 days. But when combined with the anti-inflammatory dexamethasone and the antibiotic vancomycin, the drug’s lethality increases. The three drugs used together cause acute kidney failure in up to 45 percent of patients in a five-day span. (Related: The dangers of remdesivir to treat COVID-19 patients in hospitals – Brighteon.TV.)
Olszewski ultimately criticizes the refusal to recommend HCQ and zinc as part of COVID-19 treatment protocols, calling it a political matter. She tells Ardis: “The problem with this whole situation right now is that they made it so political. This is a humanitarian issue, … [not] a left or right issue. But they made it that way … [with] the sacrifice of patient lives, and that is an absolute no-no in healthcare.”
She adds: “That’s why … people like you and I are just taking a stand despite the pushback and the [tarring] and feathering that we have to go through – in order to get the word out to the people [and] save their lives.”
DangerousMedicine.com has more articles about hospitals continuing to use remdesivir for COVID-19 instead of the more effective HCQ and zinc.